1. Home
  2. ITOS vs LAZR Comparison

ITOS vs LAZR Comparison

Compare ITOS & LAZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • LAZR
  • Stock Information
  • Founded
  • ITOS 2011
  • LAZR 2012
  • Country
  • ITOS United States
  • LAZR United States
  • Employees
  • ITOS N/A
  • LAZR N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • LAZR Auto Parts:O.E.M.
  • Sector
  • ITOS Health Care
  • LAZR Consumer Discretionary
  • Exchange
  • ITOS Nasdaq
  • LAZR Nasdaq
  • Market Cap
  • ITOS 270.7M
  • LAZR 246.4M
  • IPO Year
  • ITOS 2020
  • LAZR N/A
  • Fundamental
  • Price
  • ITOS $7.19
  • LAZR $4.68
  • Analyst Decision
  • ITOS Strong Buy
  • LAZR Hold
  • Analyst Count
  • ITOS 3
  • LAZR 8
  • Target Price
  • ITOS $26.00
  • LAZR $42.56
  • AVG Volume (30 Days)
  • ITOS 334.2K
  • LAZR 1.5M
  • Earning Date
  • ITOS 03-05-2025
  • LAZR 05-06-2025
  • Dividend Yield
  • ITOS N/A
  • LAZR N/A
  • EPS Growth
  • ITOS N/A
  • LAZR N/A
  • EPS
  • ITOS N/A
  • LAZR N/A
  • Revenue
  • ITOS $35,000,000.00
  • LAZR $75,025,000.00
  • Revenue This Year
  • ITOS N/A
  • LAZR $2.79
  • Revenue Next Year
  • ITOS $121.70
  • LAZR $68.80
  • P/E Ratio
  • ITOS N/A
  • LAZR N/A
  • Revenue Growth
  • ITOS 177.89
  • LAZR 27.61
  • 52 Week Low
  • ITOS $6.67
  • LAZR $4.48
  • 52 Week High
  • ITOS $18.75
  • LAZR $34.80
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 48.18
  • LAZR 39.47
  • Support Level
  • ITOS $6.73
  • LAZR $4.49
  • Resistance Level
  • ITOS $7.32
  • LAZR $5.04
  • Average True Range (ATR)
  • ITOS 0.38
  • LAZR 0.46
  • MACD
  • ITOS 0.03
  • LAZR -0.04
  • Stochastic Oscillator
  • ITOS 53.06
  • LAZR 12.17

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About LAZR Luminar Technologies Inc.

Luminar Technologies Inc is an automotive technology company ushering in a new era of vehicle safety and autonomy. It operates its business through the following segments: Autonomy Solutions and advanced Technologies and Services. The majority of revenue is earned from the Autonomy Solutions segment which engaged in the design, manufacturing, and sale of LiDAR sensors catering mainly to the OEMs in the automobile, commercial vehicle, robo-taxi, and adjacent industries and advanced Technologies and Services provides semiconductors and related components, as well as design, test and consulting services to the Autonomy Solutions segment and various third-party customers, including government agencies and defense contractors, in markets generally unrelated to autonomous vehicles.

Share on Social Networks: